Oxeia Biopharmaceuticals Inc

Energesis Pharmaceuticals, Inc., located in Boston, MA, is at the forefront of developing innovative therapeutics aimed at achieving effective and sustainable weight loss for individuals struggling with obesity. Their unique approach focuses on increasing energy expenditure through the enhancement of brown adipose tissue (BAT), setting them apart from traditional appetite suppressants. The company's advanced drug candidates promote the recruitment of new brown fat cells from stem progenitor cells, thereby facilitating significant fat loss without impacting lean muscle mass. By harnessing the natural physiological properties of BAT, Energesis aims to address critical unmet needs in obesity treatment while offering synergistic benefits when used alongside existing GLP-1 agents. Generated from the website

Rhythm Pharmaceuticals, Inc., based in Boston, MA, is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases. The company focuses on advancing care and precision medicines that address the root causes of conditions such as hyperphagia and obesity. Committed to a community-centered approach, Rhythm Pharmaceuticals envisions a world where patients and their families can live their fullest lives through optimal, stigma-free care. Their innovative pipeline includes treatment options tailored for individuals with unique medical needs, highlighting their passion for helping patients thrive. Generated from the website

Paratek Pharmaceuticals is a privately held biopharmaceutical company, which is engaged in the discovery and commercialization of new therapeutics that treat life-threatening infectious and other serious diseases. The company s mission at its founding was to overcome the major worldwide problem of bacterial resistance through the application of its proprietary technologies. Paratek was founded in 1996 by Dr. Stuart B. Levy, professor at Tufts University School of Medicine, and by Dr. Walter Gilbert, a Nobel Prize-winning professor emeritus at Harvard University. The company utilizes two scientific platforms to develop multiple products to combat, cure and prevent infectious and other serious diseases. Paratek Pharmaceuticals is headquartered in Boston.